Daewoong pharmaceutical

069620.KO

111.74 USD

-0.95

-0.84%

Overview

Last close

111.74 usd

Market cap

1.29B usd

52 week high

134.42 usd

52 week low

76.68 usd

Target price

147.21 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.2479

Price/Book Value

2.1866

Enterprise Value

1.67B usd

EV/Revenue

1.627

EV/EBITDA

14.3498

Key financials

Revenue TTM

1.03B usd

Gross Profit TTM

533.47M usd

EBITDA TTM

159.75M usd

Earnings per Share

N/A usd

Dividend

0.4 usd

Total assets

1.61B usd

Net debt

418.75M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.